A detailed history of Optima Capital LLC transactions in Exact Sciences Corp stock. As of the latest transaction made, Optima Capital LLC holds 21 shares of EXAS stock, worth $1,407. This represents 0.0% of its overall portfolio holdings.

Number of Shares
21
Holding current value
$1,407
% of portfolio
0.0%

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2025

Jan 23, 2026

BUY
$56.19 - $69.63 $1,179 - $1,462
21 New
21 $2.13 Million

Others Institutions Holding EXAS

About EXACT SCIENCES CORP


  • Ticker EXAS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 176,960,000
  • Market Cap $11.9B
  • Description
  • Exact Sciences Corporation provides cancer screening and diagnostic test products in the United States and internationally. The company offers Cologuard, a non-invasive stool-based DNA screening test to detect DNA and hemoglobin biomarkers associated with colorectal cancer and pre-cancer. It also provides Oncotype DX, a gene expression tests for...
More about EXAS
Track This Portfolio

Track Optima Capital LLC Portfolio

Follow Optima Capital LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Optima Capital LLC, based on Form 13F filings with the SEC.

News

Stay updated on Optima Capital LLC with notifications on news.